Literature DB >> 21474912

Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.

Nobuhisa Ishikawa1, Noboru Hattori, Sonosuke Tanaka, Yasushi Horimasu, Yoshinori Haruta, Akihito Yokoyama, Nobuoki Kohno, Vuokko L Kinnula.   

Abstract

BACKGROUND: Recent clinical studies have suggested that serum surfactant protein (SP) A, SP-D and Krebs von den Lungen-6 (KL-6) are potential biomarkers for interstitial lung diseases. Serum levels of SP-A and SP-D have also been found to be elevated in chronic obstructive pulmonary disease (COPD), but their significance has not been evaluated or compared in induced sputum samples obtained directly from the airways.
OBJECTIVE: A sequential sputum analysis was conducted to assess the value of SP-A, SP-D and KL-6 levels in COPD.
METHODS: The study material consisted of induced sputum samples from 61 subjects, 28 with COPD and 33 with prolonged cough (cough lasting >3 weeks and normal spirometry). Sputum was collected in 3 fractions (3 periods of 5 min each). Sputum levels of these proteins were measured, and receiver operating characteristic curve analysis was carried out to evaluate the sensitivity, specificity and area under the curve (AUC) for each fraction.
RESULTS: The levels of SP-A, SP-D and KL-6 were higher in patients with COPD than in those with prolonged cough in each of the fractions. Sputum levels of these proteins correlated inversely with obstruction and positively with ageing, smoking history, sputum macrophages and eosinophils. Sputum fractionation had a relatively minor effect on the levels and AUC of these proteins.
CONCLUSION: Sequential sputum analysis from 3 consecutive fractions indicated a significant difference in the levels of SP-A, SP-D and KL-6 between COPD and prolonged cough. However, sputum fractionation itself had a relatively minor effect on the levels of these proteins.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474912     DOI: 10.1159/000324539

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  15 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

2.  Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study.

Authors:  Shoko Isoyama; Nobuhisa Ishikawa; Kosuke Hamai; Mirai Matsumura; Hiroki Kobayashi; Akio Nomura; Sayaka Ueno; Takuya Tanimoto; Hiroyuki Maeda; Hiroshi Iwamoto; Noboru Hattori
Journal:  Intern Med       Date:  2022-06-01       Impact factor: 1.282

4.  Enhancement of COPD biological networks using a web-based collaboration interface.

Authors:  Stephanie Boue; Brett Fields; Julia Hoeng; Jennifer Park; Manuel C Peitsch; Walter K Schlage; Marja Talikka; Ilona Binenbaum; Vladimir Bondarenko; Oleg V Bulgakov; Vera Cherkasova; Norberto Diaz-Diaz; Larisa Fedorova; Svetlana Guryanova; Julia Guzova; Galina Igorevna Koroleva; Elena Kozhemyakina; Rahul Kumar; Noa Lavid; Qingxian Lu; Swapna Menon; Yael Ouliel; Samantha C Peterson; Alexander Prokhorov; Edward Sanders; Sarah Schrier; Golan Schwaitzer Neta; Irina Shvydchenko; Aravind Tallam; Gema Villa-Fombuena; John Wu; Ilya Yudkevich; Mariya Zelikman
Journal:  F1000Res       Date:  2015-01-29

Review 5.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

6.  An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Authors:  Annapurna Nayak; Eswari Dodagatta-Marri; Anthony George Tsolaki; Uday Kishore
Journal:  Front Immunol       Date:  2012-06-07       Impact factor: 7.561

7.  Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.

Authors:  Francesco Blasi; Paolo Tarsia; Marco Mantero; Letizia C Morlacchi; Federico Piffer
Journal:  Ther Clin Risk Manag       Date:  2013-02-12       Impact factor: 2.423

8.  Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.

Authors:  Nobuhisa Ishikawa; Noboru Hattori; Nobuoki Kohno; Akihiro Kobayashi; Tomoyuki Hayamizu; Malcolm Johnson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-23

9.  Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study.

Authors:  Mona Lärstad; Ann-Charlotte Almstrand; Per Larsson; Björn Bake; Sven Larsson; Evert Ljungström; Ekaterina Mirgorodskaya; Anna-Carin Olin
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

10.  Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease.

Authors:  Berna Akinci Ozyurek; Sevinc Sarinc Ulasli; Serife Savas Bozbas; Nilufer Bayraktar; Sule Akcay
Journal:  Multidiscip Respir Med       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.